Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03767517 · ClinicalTrials.gov registry record · NA
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
A NA study of Cancer and Stroke, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
- 4
- Study locations
NCT03767517: Completed NA study of Cancer and Stroke, sponsored by University of Alabama at Birmingham.
NCT03767517 is a NA study of Cancer and Stroke that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 209 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03767517, a NA study of Cancer and Stroke, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
- 4
- Study locations
Study Summary
Rural patients with life-limiting illness are at very high risk of not receiving appropriate care due to a lack of health professionals, long distances to treatment centers, and limited palliative care (PC) clinical expertise. Secondly, although culture strongly influences people's response to diagnosis, illness and treatment preferences, culturally-based care models are not currently available for most seriously-ill rural patients and their family caregivers. Lack of sensitivity to cultural differences may compromise PC for minority patients. The purpose of this study is to compare a culturally-based Tele-consult program to usual hospital care to determine whether a culturally-based PC Tele-consult program leads to lower symptom burden in hospitalized African American and White older adults with a life-limiting illness.
Primary Outcome
Change from baseline in patient-reported symptom burden measured using the Edmonton Symptom Assessment Scale (ESAS) at baseline; change from baseline measured using the ESAS at 7 days post-baseline. Each item is scored using: 0-10 (0= no pain; 10= worst possible pain), yielding a total score between 0 and 90. A higher value represents the worse possible outcome. Higher score indicates higher symptom burden.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Active Intervention
Study Locations (4)
Mississippi
- Anderson Regional Medical Center - Meridian
- Highland Community Hospital - Picayune
Alabama
- Russell Medical Center - Alexander City
South Carolina
- Aiken Regional Medical Center - Aiken
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2020-08-24 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
What the finished NCT03767517 record still lists
NCT03767517 is an interventional study that assigns participants to a tested intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower).
The record links to 8 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT03767517 reports a single indexed study location in Mississippi, Alabama, South Carolina.
Frequently Asked Questions
What is clinical trial NCT03767517 about?
NCT03767517 is a clinical study titled "A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders". Rural patients with life-limiting illness are at very high risk of not receiving appropriate care due to a lack of health professionals, long distances to treatment centers, and limited palliative care (PC) clinical expertise. Secondly, although culture strongly influences people's response to diagn...
What is the current status of trial NCT03767517?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2020-08-24. Estimated completion is 2024-08-30.
What conditions does trial NCT03767517 study?
This clinical trial studies the following conditions: Cancer, Stroke, Sepsis, Cardiac Disease, Pulmonary Disease.
What interventions are being tested in trial NCT03767517?
The interventions under investigation include: Usual Care (OTHER), Active Intervention (OTHER).
Who is sponsoring clinical trial NCT03767517?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03767517 being conducted?
This trial has 4 study locations across Alabama, Mississippi, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03767517's enrollment target sits among peer trials
209 226th of 615 higher than 390 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI